These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 7347855)
21. [Principles and practical advice for drug dosages in liver diseases. I]. Saudek F Cas Lek Cesk; 1984 Apr; 123(14):416-20. PubMed ID: 6713468 [No Abstract] [Full Text] [Related]
22. The 1986 Bernard B. Brodie award lecture. The genetic regulation of drug-metabolizing enzymes. Nebert DW Drug Metab Dispos; 1988; 16(1):1-8. PubMed ID: 2894936 [No Abstract] [Full Text] [Related]
23. [Drug kinetics in liver disease]. Saudek F Cas Lek Cesk; 1984 Feb; 123(7):181-5. PubMed ID: 6697366 [No Abstract] [Full Text] [Related]
24. Impact of hepatitis B and C virus infection on the clinical prognosis of alcoholic liver cirrhosis. Yamanaka T; Shiraki K; Nakazaawa S; Okano H; Ito T; Deguchi M; Takase K; Nakano T Anticancer Res; 2001; 21(4B):2937-40. PubMed ID: 11712790 [TBL] [Abstract][Full Text] [Related]
25. The keratin cytoskeleton in liver diseases. Zatloukal K; Stumptner C; Fuchsbichler A; Fickert P; Lackner C; Trauner M; Denk H J Pathol; 2004 Nov; 204(4):367-76. PubMed ID: 15495250 [TBL] [Abstract][Full Text] [Related]
26. Analysis of risk factors for hepatocellular carcinoma in patients with HBs antigen- and anti-HCV antibody-negative alcoholic cirrhosis: clinical significance of prior hepatitis B virus infection. Uetake S; Yamauchi M; Itoh S; Kawashima O; Takeda K; Ohata M Alcohol Clin Exp Res; 2003 Aug; 27(8 Suppl):47S-51S. PubMed ID: 12960507 [TBL] [Abstract][Full Text] [Related]
28. The liver and circulating thyroid hormones. Klachko DM; Johnson ER J Clin Gastroenterol; 1983 Oct; 5(5):465-71. PubMed ID: 6313798 [TBL] [Abstract][Full Text] [Related]
29. [Drug therapy in liver diseases]. Zilly W Med Klin; 1979 Oct; 74(43):1575-80. PubMed ID: 44540 [No Abstract] [Full Text] [Related]
30. Proteomics in the study of liver pathology. Parent R; Beretta L J Hepatol; 2005 Jul; 43(1):177-83. PubMed ID: 15894398 [No Abstract] [Full Text] [Related]
31. Disposition of valproic acid in patients with liver disease. Klotz U; Rapp T; Müller WA Eur J Clin Pharmacol; 1978 Mar; 13(1):55-60. PubMed ID: 346355 [No Abstract] [Full Text] [Related]
32. [Metabolism of drugs in the liver and disease]. Sonne J; Døssing M; Loft S Ugeskr Laeger; 1988 Jan; 150(4):204-9. PubMed ID: 3376323 [No Abstract] [Full Text] [Related]
33. Altered drug metabolism and elevated serum bile acids in liver disease: a unified pharmacokinetic explanation. Gilmore IT; Hofmann AF Gastroenterology; 1980 Jan; 78(1):177-9. PubMed ID: 7350025 [No Abstract] [Full Text] [Related]
34. [Genetic significance of determined oxidation of drugs and xenobiotics in the pathogenesis of neoplastic diseases]. Niewiński P; Orzechowska-Juzwenko K Pol Merkur Lekarski; 1997 Jan; 2(7):71-5. PubMed ID: 9296908 [No Abstract] [Full Text] [Related]
35. [Characteristics of drug therapy in kidney and liver insufficiency, in infancy and old age, during pregnancy and lactation]. Rameis H Wien Med Wochenschr; 1983 Mar; 133(6):141-51. PubMed ID: 6858179 [No Abstract] [Full Text] [Related]
39. [The role of genetically determined oxidation of drugs and xenobiotics in pathogenesis of neoplastic diseases]. Niewiński P; Orzechowska-Juzwenko K Postepy Hig Med Dosw; 1996; 50(4):321-32. PubMed ID: 9019742 [TBL] [Abstract][Full Text] [Related]